A large agreement, a different measure
Cerebras closed Friday at $166.43 after losing nearly 20% over the week. Its market capitalization, $95 billion after the first trading day, is now just over $39 billion. Those values show how far the aggregate price investors assigned to the company has changed. The first-day figure was an observed valuation, not an earnings forecast or analyst consensus. Reading the decline therefore means separating the optimism reflected in that price from the commercial agreement the company actually disclosed.[1]
The January agreement with OpenAI, worth more than $10 billion, covers 750 megawatts of computing power through 2028. Cerebras makes inference chips and rents their capacity through cloud services from its data centers. Contract value and stock-market capitalization measure different things. The agreement describes a source of operating revenue. Assessing total company profit and the price paid for it requires a separate profitability calculation.[1]
Selling rights and executed sales
This week introduced another quantity beside the price. Up to 19.4 million shares became eligible for sale on Wednesday, equivalent to 8% of shares outstanding. The group extends beyond senior executives to directors, non-executive employees and other holders. The end of the restriction grants those holders an option. That option is distinct from an executed sale in the market.[1]
Andrew Feldman and Sean Lie’s sales of more than $240 million of Class A stock between August 20 and September 25 were actual transactions. But those sales, made under plans adopted after the IPO, cannot stand in for evidence that every share released on Wednesday was sold. The periods and covered holders differ. Newly available shares can create supply pressure; attributing the entire weekly decline to that mechanism requires more information about executed share flows and buyer demand. An alternative is that investors have reduced the value they assign to future operating revenue.[1]
The distinction within the price
The two mechanisms pose different questions. Shares becoming available to trade concern the price at which existing buyers are willing to absorb more stock. Reassessment of operating revenue concerns how much revenue and profit the same capacity generates from customers. The expiry changes holders’ ability to sell existing shares. Customer revenue and company profit arise from the computing business. The 750-megawatt agreement belongs to that operating business; the newly available shares remain part of the supply facing buyers.[1]
A reading that preserves this distinction does not turn the closing price into a buy or sell recommendation. For the supply explanation, the discriminating observations are the extent to which newly available selling rights are used and the trading demand meeting those shares. For the operating explanation, they are the conversion of rented capacity into revenue and profit. Friday’s price brings those questions together while leaving the contribution of each unresolved. The issue is which cash expectations and which share supply the valuation carries together.[1]